Progestin, the synthetic version of the hormone progesterone, works throughout your body in ways that go well beyond preventing pregnancy. It thickens cervical mucus, thins the uterine lining, shifts your metabolism, influences your mood through brain chemistry, and can alter your cholesterol profile. The specific effects depend heavily on which type of progestin you’re using and how it’s delivered.
How Progestin Works at the Cellular Level
Your cells have progesterone receptors that act like locks, and progestin fits into them like a key. When progestin binds to these receptors, it triggers a chain reaction: the receptor changes shape, attaches to your DNA, and switches certain genes on or off. This is the same basic process your body’s own progesterone uses, which is why synthetic progestins can mimic so many of progesterone’s effects. The difference is that various synthetic progestins also fit into other hormone receptors, including those for androgens (male-type hormones) and mineralocorticoids (which regulate fluid balance), producing a wider and sometimes unpredictable range of effects.
Effects on the Reproductive System
Progestin’s most well-known job is changing the conditions inside your reproductive tract to prevent pregnancy. It does this through three main mechanisms. First, it thickens your cervical mucus, creating a barrier that makes it difficult for sperm to reach the uterus. Second, it thins the uterine lining so a fertilized egg is less likely to implant. Third, depending on the dose and delivery method, it can suppress the hormonal signals from your brain that trigger ovulation.
That suppression works through a feedback loop. Normally, your brain releases signaling hormones (FSH and LH) that tell your ovaries to mature and release an egg. Progestin mimics the signal your body uses to shut down that process after ovulation has already occurred, essentially tricking the brain into thinking ovulation already happened. Higher-dose methods like the injection are more reliable at fully blocking ovulation, while lower-dose options like the hormonal IUD primarily work through the cervical mucus and uterine lining changes.
Weight and Metabolism
Weight gain is one of the most commonly reported concerns with progestin, but the picture varies dramatically by method. Most studies show average weight gain of less than 2 kg (about 4.4 pounds) at 6 to 12 months for most progestin-only methods. The major exception is the injectable form (DMPA, commonly known as Depo-Provera).
In a large retrospective study, women using the injection gained significantly more weight than those using a non-hormonal copper IUD: about 2.3 kg more in the first year, and the gap widened to 3.2 kg by year three. A longer-term study found the difference reached 1.7 kg by year ten (6.6 kg total for injection users versus 4.9 kg for copper IUD users). The weight isn’t just water retention. A prospective study in adolescents found that injection users had an 11% greater increase in body fat compared to those not using hormonal methods, along with a 4% greater decrease in lean body mass. This suggests the injection shifts body composition toward more fat and less muscle.
Hormonal IUDs show a smaller but still measurable effect on body composition. Users gained about 2.5% more body fat than non-users in one study, and lost more lean mass. Progestin also appears to reduce insulin sensitivity, particularly with implants and injectables, meaning your body becomes less efficient at processing blood sugar.
Mood and Brain Chemistry
Progestin’s influence on mood is complex and follows a pattern that surprises many people. Your body breaks progesterone (and some synthetic progestins) down into a compound called allopregnanolone, which directly interacts with the same brain receptors targeted by anti-anxiety medications. At higher concentrations, this compound produces calming, anti-anxiety, and even sedative effects. At low concentrations, it can intensify irritability and aggression.
The relationship between this compound and mood follows an inverted U-shaped curve. Moderate, stable levels tend to support a calm mood, while very low or rapidly fluctuating levels can trigger negative mood symptoms. This helps explain why some women feel emotionally stable on progestin while others experience depression or irritability. It also explains why the transition points, like starting or stopping a progestin method, or the premenstrual drop in progesterone, are often the worst times for mood symptoms.
Progestin and its metabolites also affect serotonin, dopamine, and norepinephrine, the three neurotransmitter systems most closely linked to mood regulation. There’s also a progesterone receptor in the amygdala, the brain region central to processing emotions like fear and anxiety. Women who develop premenstrual dysphoric disorder may have decreased sensitivity to these calming compounds, or naturally produce less of them, making them more vulnerable to mood disruption from any progestin-containing method.
Cholesterol and Cardiovascular Effects
Not all progestins affect your heart and blood vessels equally. Progestins with stronger androgenic (male hormone-like) properties tend to lower HDL cholesterol, the protective type, in a dose-dependent way. Medroxyprogesterone acetate (the progestin in Depo-Provera and many older hormone replacement therapies) is a notable example, shown to blunt the HDL-raising benefits of estrogen when the two are used together.
Newer progestins tell a different story. Drospirenone combined with estradiol actually increased HDL while lowering total and LDL cholesterol. Some progestins like nomegestrol acetate appear to have no significant effect on clotting factors or cholesterol markers at all. In the Women’s Health Initiative trial, the combination of conjugated estrogen with medroxyprogesterone carried a higher risk of blood clots than estrogen alone, reinforcing that the type of progestin matters for cardiovascular safety.
Bone Density
The injectable form of progestin stands out again here, and not in a good way. Depo-Provera use is associated with measurable bone mineral density loss, and the loss increases the longer you use it. The good news is that bone density appears to recover after stopping, but the timeline depends on how long you used it and which bones you’re looking at.
For women who used the injection for less than two years, studies show substantial to full recovery at the spine, hip, and femoral neck within about five years of stopping. For those who used it for two years or more, spine density tends to bounce back, but hip recovery can remain incomplete even five years later. In adolescents who used the injection for two or more years, complete recovery at the hip and femoral neck was not observed in all participants. This is particularly relevant for younger users who are still building their peak bone mass.
Skin, Hair, and Androgenic Effects
Progestins are grouped into generations, and the generation determines whether a given progestin will worsen or improve acne and excess hair growth. First-generation progestins like norethisterone and second-generation progestins like levonorgestrel bind to androgen receptors and can trigger or worsen acne, oily skin, and unwanted hair growth. These are the progestins found in many older birth control formulations and in the hormonal IUD.
Third-generation progestins (norgestimate, gestodene, desogestrel) have significantly less androgenic activity. Fourth-generation progestins were specifically designed to avoid androgenic effects entirely. Drospirenone, derived from spironolactone (a drug used to treat hormonal acne), improved skin quality including seborrhea, acne, and excess hair in clinical studies. Dienogest goes even further: it’s more anti-androgenic than drospirenone, improving acne in 52% to 66% of treated patients across multiple studies. These effects happen because androgens are converted into their most potent form (DHT) inside sebaceous glands and hair follicles, and anti-androgenic progestins interfere with that conversion.
Why the Delivery Method Matters
The way progestin enters your body shapes how strongly you feel its systemic effects. A hormonal IUD releases progestin directly into the uterus, resulting in low, stable blood levels that minimize metabolic side effects like weight gain and cholesterol changes while still providing strong local effects on the uterine lining and cervical mucus. An implant also provides low, stable hormone levels but delivers them into the bloodstream, producing somewhat more systemic effects. Oral pills create daily peaks and valleys as each dose is absorbed and metabolized. The injection delivers the highest systemic dose, which is why it tends to produce the most pronounced effects on weight, bone density, and metabolism.
This means that switching delivery methods, even without changing the underlying goal of progestin-based contraception, can substantially change which side effects you experience. A woman who gains weight on the injection may not on a hormonal IUD. Someone who gets acne on a levonorgestrel-containing method may see their skin clear on a pill containing dienogest or drospirenone. The effects of “progestin” on your body are really the effects of a specific progestin, at a specific dose, delivered in a specific way.